Bumper Offer - Urjas oil Just @ Rs. 1
Metolar XR 12.5 Capsule, a prescription drug, is manufactured in various forms such as Capsule. It is typically used for the treatment of High BP. Metolar XR 12.5 Capsule also has some secondary and off-label uses. These are listed below.
The right dosage of Metolar XR 12.5 Capsule depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Metolar XR 12.5 Capsule are Slow heart rate (pulse). While these are the most often observed Metolar XR 12.5 Capsule side effects, there are can be others also. These have been listed below. Normally, these side effects of Metolar XR 12.5 Capsule are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Metolar XR 12.5 Capsule is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Metolar XR 12.5 Capsule related warnings talks about Metolar XR 12.5 Capsule's effects on the liver, heart and kidney.
Metolar XR 12.5 Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Metolar XR 12.5 Capsule in conditions like Bradycardia (Slow Heart Rate). Some other conditions that can be affected by Metolar XR 12.5 Capsule are listed in the contraindications section below.
Besides this, Metolar XR 12.5 Capsule may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Metolar XR 12.5 Capsule is not safe while driving, and is is not addictive in nature.
Metolar XR 12.5 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Metolar XR 12.5 Capsule is used -
Moderate
Mild
Common
Is the use of Metolar XR 12.5 Capsule safe for pregnant women?
Metolar has many dangerous side effects in pregnant women. If you are pregnant, do not consume Metolar without medical advice.
Is the use of Metolar XR 12.5 Capsule safe during breastfeeding?
Metolar may have very limited harmful effects for breastfeeding women.
What is the effect of Metolar XR 12.5 Capsule on the Kidneys?
Metolar is completely safe for kidneys.
What is the effect of Metolar XR 12.5 Capsule on the Liver?
Metolar is rarely harmful for the liver.
What is the effect of Metolar XR 12.5 Capsule on the Heart?
Metolar is rarely harmful for the heart.
Metolar XR 12.5 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Metolar XR 12.5 Capsule unless your doctor advises you to do so -
Is this Metolar XR 12.5 Capsule habit forming or addictive?
Metolar XR 12.5 Capsule does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Metolar XR 12.5 Capsule, you should not drive or work on any heavy machine, as Metolar XR 12.5 Capsule can make you drowsy.
Is it safe?
Yes, but consume Metolar XR 12.5 Capsule only on doctor's advice.
Is it able to treat mental disorders?
Metolar XR 12.5 Capsule is unable to treat or cure mental disorders.
Interaction between Food and Metolar XR 12.5 Capsule
When consumed with certain foods, Metolar XR 12.5 Capsule may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Metolar XR 12.5 Capsule
Consumption of alcohol and Metolar XR 12.5 Capsule together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
